China Life Insurance (SEHK:2628) Q3 Results Deepen Fears Of A Value Trap
China Life Insurance went into its Q3 2026 report looking like a deep value story, trading at HK$23.88 after a rough 30-day stretch that left the stock down about 15%. The narrative has been about cheap earnings and a big discount to intrinsic value. The fresh quarter tells a harder truth. Management posted a quarterly revenue loss of ¥30.2b and a net loss of ¥45.1b, a sharp hit for a life insurer that depends on investment income and actuarial stability. The share price reaction now has to...
China Life Insurance went into its Q3 2026 report looking like a deep value story, trading at HK$23.88 after a rough 30-day stretch that left the stock down about 15%. The narrative has been about cheap earnings and a big discount to intrinsic value. The fresh quarter tells a harder truth. Management posted a quarterly revenue loss of ¥30.2b and a net loss of ¥45.1b, a sharp hit for a life insurer that depends on investment income and actuarial stability. The share price reaction now has to...
What's Your Reaction?
